We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy


Formulating Cannabinoid Particles for Therapeutics


Formulating Cannabinoid Particles for Therapeutics

Who's speaking at this Webinar?

Dr Natalia Sannikova
Research & Development Manager, Ascension Sciences
Tomas Skrinskas
Founder & CEO, Ascension Sciences

Recent literature increasingly supports the therapeutic use of cannabinoids in the development of novel medicines. Nanoparticles play a crucial role in increasing the solubility, stability, benefits and safety of cannabinoids as therapeutic agents. In this webinar, we review the challenges of cannabinoid-based drug development, and present the opportunities of nanotechnology in formulating cannabinoid nanoparticles.

During this webinar we will discuss:

  • Clinical Snapshot: History and challenges of cannabinoid-based drug development.
  • Technology Overview: Opportunities in nanotechnology and the microfluidic approach.
  • Characterization Methods: ELISA for dissolution studies.
  • Sample Preparation Challenges: Polymer nanoparticles, liposomes, emulsions on the HPLC.
  • Research Findings: The impact of lipid composition on liposome stability and cannabinoid drug encapsulation efficiency


Like what you just read? You can find similar content on the communities below.

Analysis & Separations Applied Sciences

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free